Stock & Company Details
Cadrenal Therapeutics Inc $CVKD
Price:
N/A
N/A
3.6M
$7M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.34
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
CVKD technical indicators
Latest Cadrenal Therapeutics Inc (CVKD) indicator readings as of 2026-11-19.
CVKD's 14-day RSI is 65.9, in neutral territory. ADX reads 37.2, indicating a trending market. MACD (12, 26, 9) is 0.17, above the zero line.
Overview
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
Finance Bot
Ask your questions
Start by typing a question below.